White, Dr. Patrick J. (Department of Psychiatry, University of Alberta)
Alberta Blue Cross
Coverage for injectable antipsychotic drugs, proposal for ... CS52-53
Alberta Health Care Insurance Plan
Coverage for injectable antipsychotic drugs, proposal for ... CS52-53 Coverage for psychological care, proposal for ... CS51-52
Alberta Hospital
Rehabilitation unit for patients with dual diagnosis ... CS51
Alberta Mental Health Board
Task force on CTOs ... CS53
Assertive community treatment
Benefits for mentally ill patients ... CS49-52
Canadian Psychiatric Association
For increased funding for community services ... CS53
College of Physicians and Surgeons of Alberta
CTOs and psychologists, views on role of ... CS51-52
Community treatment orders
Balance of rights and personal health re ... CS50-51, 53 Benefits of, cycles of illness and treatment ... CS49, 53 Benefits of, economic ... CS49-50 Benefits of, suicide prevention ... CS50 Number of CTOs, rural vs. urban ... CS50 Other jurisdictions, Australia and New Zealand ... CS49 Other jurisdictions, United States (New York State) ... CS50-52 Overview of ... CS49-50
Community treatment orders - Community services
Community services for patients ... CS49-53 Funding for, proposal for increase ... CS50-53 Oral presentation by U of A, Dept. of Psychiatry re ... CS49-53 Peer support models ... CS52 Role of psychologists ... CS51-52
Community treatment orders - Community services - Rural areas
Oral presentation by U of A, Dept. of Psychiatry re ... CS50-51 Shortage of services ... CS51
Community treatment orders - Consent
Consent, competent vs. incompetent patient ... CS49 Oral presentation by U of A, Dept. of Psychiatry re ... CS49 Overview of ... CS49
Community treatment orders - Inform patient re order for apprehension for noncompliance
Community treatment orders - Inform patient re rights to review
Oral presentation by U of A, Dept. of Psychiatry re ... CS50 Of right of appeal and procedures ... CS50
Community treatment orders - Issuance by health professionals
Oral presentation by U of A, Dept. of Psychiatry re ... CS51-52 By physicians ... CS51 Shortage of health professionals, impact of ... CS51 Use of telehealth and video conferencing ... CS50
Community treatment orders - Issuance by health professionals - Rural areas
By physicians ... CS50 Shortage of health professionals, impact of ... CS50, 51 Use of telepsychiatry ... CS50
Community treatment orders - Issuance criteria
Criteria ... CS49-50 Criteria, prior hospitalization ... CS50 Oral presentation by U of A, Dept. of Psychiatry re ... CS49 Other jurisdictions, Australia and New Zealand ... CS49 Other jurisdictions, Ontario ... CS49
Community treatment orders - Review panels
Existing provisions under MHA ... CS50, 53 Oral presentation by U of A, Dept. of Psychiatry re ... CS50, 53
Community treatment orders - Treatments
Early intervention ... CS49-50, 52 Funding for, proposal for increase for medication ... CS52-53
Community treatment orders - United States
Survey of patient satisfaction with ... CS50
Criminal justice system - United States - New York State
Use of CTOs (Kendra's Law) ... CS50
Crystal methamphetamine drug abuse - Treatment
Psychosis from use of ... CS49
Drug abuse - Treatment
Early intervention ... CS49
Drug abuse - United States
Impact of Kendra's Law (CTOs) on, in New York State ... CS50
Drugs, Prescription - Antipsychotic drugs
Drugs, Prescription - Antipsychotic drugs - Costs
Funding for, proposal for increased ... CS52-53 Injectable forms, proposal for coverage ... CS52-53 Other jurisdictions, funding for ... CS52-53
Dual diagnosis (mental illness and drug abuse)
Mental health services re, shortage of ... CS51
Homelessness - United States
Impact of Kendra's Law, NY (CTOs) on ... CS50, 52
Hospitals
Bed shortages, impact of CTOs on ... CS50
Involuntary admission of mental health patients - Criteria
Criteria, existing, presenting or likely to present danger to self or others ... CS53 Criteria, proposed, danger provisions, removal of, with addition of concept of harm ... CS49 Criteria, proposed, immediate harm provisions, removal of ... CS49 Criteria, proposed, substantial mental or physical deterioration or serious physical impairment ... CS49 Cycles of illness and treatment, impact on ... CS49 Oral presentation by U of A, Dept. of Psychiatry re ... CS49 Other jurisdictions, Ontario ... CS49
Medical profession - Education
History of, recommendation to reduce enrolment ... CS51-52
Mental Health Act
Involuntary admission of mental health patients, existing criteria re danger to self or others ... CS53 Review panels, existing provisions under ... CS50, 53
Mental Health Amendment Act
Balance of rights and personal health ... CS50-51 Steering committee re ... CS49
Mental Health Amendment Act Review - Oral presentations received
University of Alberta, Dept. of Psychiatry ... CS49-53
Mental health legislation - Australia and New Zealand
Use of CTOs and involuntary admission ... CS49
Mental health legislation - Canada - Ontario
Involuntary admission criteria ... CS49 Use of CTOs ... CS49
Mental health legislation - United States
Government funding for CTO injectable drugs ... CS52
Mental health legislation - United States - New York State
Use of CTOs (Kendra's Law) ... CS50-52
Mental health patients - Housing
Group homes for patients relocated from rural areas ... CS51
Mental health patients - Treatment
Cycles of illness and recovery ... CS49, 53 Early intervention ... CS49-50, 52 Use of peer support model ... CS52
Minister of Health and Wellness
Steering committee re MHAA ... CS49
Nurses
Role in CTO treatment plan ... CS51
Olanzapine (Drug)
Zyprexa (antipsychotic medication), injectable form of ... CS53
Pharmacists
Increase in insurance rates due to expanded practice provisions ... CS51
Psychiatrists - Rural areas
Shortage of, impact of ... CS51
Psychiatry
Diagnosis issues underlying ... CS50-51
Psychologists
Community services for CTO patients, proposal for ... CS51-52 Funding for, comparison, private practice vs. public system ... CS51-52 Insurance rates, potential increase in ... CS51-52 Issuance of CTOs by, proposal for ... CS51-52 Psychology aid program, proposal for ... CS51-52 Qualifications of ... CS52
Risperidone (Drug)
Risperdal Consta (injectable antipsychotic drug) ... CS52-53
Suicide - Prevention
CTOs as a suicide prevention measure ... CS50
Suicide - Prevention - United States
Impact of Kendra's Law (CTOs) on, in New York ... CS50
University of Alberta, Dept. of Psychiatry
Oral presentation re MHAA by ... CS49-53
White, Dr. Patrick J. (U of A, Dept. of Psychiatry)
Oral presentation re MHAA by ... CS49-53
|